{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:22:08Z","timestamp":1794871328768,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFA0104304"],"award-info":[{"award-number":["2017YFA0104304"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770648"],"award-info":[{"award-number":["81770648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802402"],"award-info":[{"award-number":["81802402"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900597"],"award-info":[{"award-number":["81900597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970567"],"award-info":[{"award-number":["81970567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870449"],"award-info":[{"award-number":["81870449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key R&D Program of Guangdong Province","award":["2019B020236003"],"award-info":[{"award-number":["2019B020236003"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030311034"],"award-info":[{"award-number":["2017A030311034"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A03031032"],"award-info":[{"award-number":["2018A03031032"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313043"],"award-info":[{"award-number":["2018A030313043"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2018130"],"award-info":[{"award-number":["A2018130"]}]},{"name":"Sci-tech Research Development Program of Guangzhou city","award":["158100076"],"award-info":[{"award-number":["158100076"]}]},{"name":"Young Teacher Development Program of Sun Yat-Sen University","award":["17ykpy57"],"award-info":[{"award-number":["17ykpy57"]}]},{"name":"Young Teacher Development Program of Sun Yat-Sen University","award":["19ykpy35"],"award-info":[{"award-number":["19ykpy35"]}]},{"name":"Young Teacher Development Program of Sun Yat-Sen University","award":["20ykpy41"],"award-info":[{"award-number":["20ykpy41"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M653199"],"award-info":[{"award-number":["2019M653199"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academician Shusen Lanjuan Talent foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>ABO-incompatible liver transplantation (ABO-i LT) has become a rescue therapeutic option for patients with severe hepatic failure. Although the use of rituximab greatly reduces the morbidity of antibody-mediated rejection (AMR), severe adverse effects, such as infection and biliary complications, still seriously threaten the survival of transplant recipients. The aim of this study was to evaluate the safety and feasibility of using mesenchymal stem cells (MSCs) to replace rituximab in ABO-i LT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-two patients with severe hepatic failure undergoing ABO-i LT were enrolled and randomly divided into two groups: the MSC group and the rituximab group. The safety of the application of MSCs and the incidence of allograft rejection, including antibody-mediated rejection (AMR) and acute cellular rejection (ACR), were evaluated in both groups at the 2-year follow-up period as primary endpoints. Recipients and graft survival and other postoperative complications were compared as secondary endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No severe MSC-related adverse events were observed during the trial. MSC treatment yielded comparable, if not better, results than rituximab at decreasing the incidence of acute rejection (9.1% vs 27.3%). Inspiringly, compared to those in the rituximab group, the rates of biliary complications (0% vs 45.5%) and infection (9.1% vs 81.8%) were significantly decreased in the MSC group. In addition, there were no significant differences in 2-year graft and recipient survival between the two groups (81.8% vs 72.7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data show that MSC transfusion is comparable to rituximab treatment for AMR prophylaxis following ABO-i LT. Additionally, the results indicate that MSCs are more beneficial to the prevention of infection and biliary complications and may be introduced as a novel immunosuppressive approach for ABO-i LT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Trial registration:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/chictr.org.cn\">chictr.org.cn<\/jats:ext-link>\n                      , ChiCTR2000037732. Registered 31 August 2020- Retrospectively registered,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=57074\">http:\/\/www.chictr.org.cn\/showproj.aspx?proj=57074<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02246-4","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T10:34:10Z","timestamp":1618569250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I\/II randomized, open-label, controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Yingcai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binsheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy Peng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"issue":"3","key":"2246_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","volume":"13","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13(3):131\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2246_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/tri.12531","volume":"28","author":"J Zhou","year":"2015","unstructured":"Zhou J, et al. ABO-incompatible liver transplantation for severe hepatitis B patients. Transpl Int. 2015;28(7):793\u20139.","journal-title":"Transpl Int"},{"issue":"1 Pt 2","key":"2246_CR3","first-page":"2223","volume":"21","author":"J Gugenheim","year":"1989","unstructured":"Gugenheim J, et al. Rejection of ABO incompatible liver allografts in man. Transplant Proc. 1989;21(1 Pt 2):2223\u20134.","journal-title":"Transplant Proc"},{"issue":"2","key":"2246_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hbpd.2018.02.005","volume":"17","author":"EC Lee","year":"2018","unstructured":"Lee EC, et al. A comparison of desensitization methods: rituximab with\/without plasmapheresis in ABO-incompatible living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2018;17(2):119\u201325.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"2246_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/TP.0000000000001956","volume":"102","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H, et al. Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation. Transplantation. 2018;102(1):97\u2013104.","journal-title":"Transplantation"},{"issue":"3","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jhep.2014.04.039","volume":"61","author":"GW Song","year":"2014","unstructured":"Song GW, et al. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era. J Hepatol. 2014;61(3):575\u201382.","journal-title":"J Hepatol"},{"key":"2246_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao F, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/TP.0000000000001879","volume":"102","author":"MEJ Reinders","year":"2018","unstructured":"Reinders MEJ, et al. Mesenchymal stromal cell therapy for solid organ transplantation. Transplantation. 2018;102(1):35\u201343.","journal-title":"Transplantation"},{"issue":"11","key":"2246_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307(11):1169\u201377.","journal-title":"JAMA"},{"issue":"1","key":"2246_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2017.03.001","volume":"67","author":"O Detry","year":"2017","unstructured":"Detry O, et al. Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase I-II, open-label, clinical study. J Hepatol. 2017;67(1):47\u201355.","journal-title":"J Hepatol"},{"issue":"12","key":"2246_CR11","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/sctm.17-0134","volume":"6","author":"M Shi","year":"2017","unstructured":"Shi M, et al. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection. Stem Cells Transl Med. 2017;6(12):2053\u201361.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"2246_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcyt.2016.11.005","volume":"19","author":"YC Zhang","year":"2017","unstructured":"Zhang YC, et al. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation. Cytotherapy. 2017;19(2):194\u20139.","journal-title":"Cytotherapy"},{"issue":"1","key":"2246_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/ajt.13444","volume":"16","author":"GW Song","year":"2016","unstructured":"Song GW, et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am J Transplant. 2016;16(1):157\u201370.","journal-title":"Am J Transplant"},{"key":"2246_CR14","volume":"3","author":"KS Gurusamy","year":"2012","unstructured":"Gurusamy KS, et al. Techniques of flushing and reperfusion for liver transplantation. Cochrane Database Syst Rev. 2012;3:CD007512.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2246_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"2","key":"2246_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas M, et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18(2):293\u2013307.","journal-title":"Am J Transplant"},{"issue":"10","key":"2246_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/lt.23948","volume":"20","author":"JG O'Leary","year":"2014","unstructured":"O'Leary JG, et al. Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features. Liver Transpl. 2014;20(10):1244\u201355.","journal-title":"Liver Transpl"},{"issue":"5","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ultrasmedbio.2012.12.004","volume":"39","author":"J Ren","year":"2013","unstructured":"Ren J, et al. Revealing impaired blood supply to the bile ducts on contrast-enhanced ultrasound: a novel diagnosis method to ischemic-type biliary lesions after orthotropic liver transplantation. Ultrasound Med Biol. 2013;39(5):753\u201360.","journal-title":"Ultrasound Med Biol"},{"key":"2246_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejrad.2018.07.009","volume":"106","author":"P Boraschi","year":"2018","unstructured":"Boraschi P, et al. Biliary complications after liver transplantation: assessment with MR cholangiopancreatography and MR imaging at 3T device. Eur J Radiol. 2018;106:46\u201355.","journal-title":"Eur J Radiol"},{"issue":"2","key":"2246_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5966\/sctm.2015-0001","volume":"5","author":"YP Fan","year":"2016","unstructured":"Fan YP, et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat peritoneal dialysis-induced fibrosis. Stem Cells Transl Med. 2016;5(2):235\u201347.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"2246_CR21","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"key":"2246_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fimmu.2015.00560","volume":"6","author":"P Mattar","year":"2015","unstructured":"Mattar P, Bieback K. Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol. 2015;6:560.","journal-title":"Front Immunol"},{"issue":"4","key":"2246_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1517\/14712598.2011.557060","volume":"11","author":"JE Carroll","year":"2011","unstructured":"Carroll JE, Mays RW. Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther. 2011;11(4):463\u201371.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"2246_CR24","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","volume":"4","author":"M Eapen","year":"2017","unstructured":"Eapen M, et al. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. Lancet Haematol. 2017;4(7):e325\u201333.","journal-title":"Lancet Haematol"},{"issue":"1","key":"2246_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MNH.0000000000000461","volume":"28","author":"F Casiraghi","year":"2019","unstructured":"Casiraghi F, Remuzzi G. Mesenchymal stromal cells in kidney transplantation. Curr Opin Nephrol Hypertens. 2019;28(1):40\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2246_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0029-1192058","volume":"29","author":"SJ Knechtle","year":"2009","unstructured":"Knechtle SJ, Kwun J. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis. 2009;29(1):91\u2013101.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"2246_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/17435390903470093","volume":"4","author":"Y Ramot","year":"2010","unstructured":"Ramot Y, et al. Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells. Nanotoxicology. 2010;4(1):98\u2013105.","journal-title":"Nanotoxicology"},{"issue":"4","key":"2246_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1574888X11666160201115733","volume":"11","author":"N Serakinci","year":"2016","unstructured":"Serakinci N, Kalkan R, Tulay P. Double faced role of human mesenchymal stem cells and their role challenges in cancer therapy. Curr Stem Cell Res Ther. 2016;11(4):343\u201351.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"11","key":"2246_CR29","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1097\/01.TP.0000082723.02477.87","volume":"76","author":"I Monteiro","year":"2003","unstructured":"Monteiro I, et al. Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation. 2003;76(11):1648\u20139.","journal-title":"Transplantation"},{"issue":"1","key":"2246_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/ajt.12520","volume":"14","author":"H Egawa","year":"2014","unstructured":"Egawa H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant. 2014;14(1):102\u201314.","journal-title":"Am J Transplant"},{"issue":"5","key":"2246_CR31","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/hep.22236","volume":"47","author":"D van Poll","year":"2008","unstructured":"van Poll D, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47(5):1634\u201343.","journal-title":"Hepatology"},{"issue":"1","key":"2246_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-6143.2009.02785.x","volume":"10","author":"N Kamar","year":"2010","unstructured":"Kamar N, et al. Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant. 2010;10(1):89\u201398.","journal-title":"Am J Transplant"},{"key":"2246_CR33","doi-asserted-by":"crossref","unstructured":"Luna G, et al. Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies. JAMA Neurol. 2020;77(2):184-91.","DOI":"10.1001\/jamaneurol.2019.3365"},{"issue":"7","key":"2246_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/TP.0b013e31824612b5","volume":"93","author":"T Tanabe","year":"2012","unstructured":"Tanabe T, et al. Endothelial chimerism after ABO-incompatible kidney transplantation. Transplantation. 2012;93(7):709\u201316.","journal-title":"Transplantation"},{"issue":"8","key":"2246_CR35","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","volume":"32","author":"S Iacob","year":"2012","unstructured":"Iacob S, et al. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int. 2012;32(8):1253\u201361.","journal-title":"Liver Int"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T10:45:45Z","timestamp":1618569945000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02246-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-111230\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design was approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. All included patients were informed about the nature of the study and gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed a consent form for their data to be used for research or publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}